Dupilumab De-escalation in Pediatric Atopic Dermatitis
Trial terminated
Also in this update: Final enrollment: 1 participants — 3% of the 30 planned; Primary completion date changed from estimate of Apr 1, 2027 to Jul 18, 2026
Johns Hopkins UniversityPhase 4 NCT06116526 Registry history of NCT06116526 on ClinicalTrials.gov (opens the registry)